OncoSec Medical Total Debt vs. Cash Per Share

ONCSDelisted Stock  USD 0.06  0  3.63%   
Taking into consideration OncoSec Medical's profitability measurements, OncoSec Medical may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess OncoSec Medical's ability to earn profits and add value for shareholders.
For OncoSec Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of OncoSec Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well OncoSec Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between OncoSec Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of OncoSec Medical over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Please note, there is a significant difference between OncoSec Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if OncoSec Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OncoSec Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

OncoSec Medical Cash Per Share vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining OncoSec Medical's current stock value. Our valuation model uses many indicators to compare OncoSec Medical value to that of its competitors to determine the firm's financial worth.
OncoSec Medical is regarded third in total debt category among its peers. It is rated below average in cash per share category among its peers . The ratio of Total Debt to Cash Per Share for OncoSec Medical is about  12,349,530 . Comparative valuation analysis is a catch-all technique that is used if you cannot value OncoSec Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

OncoSec Total Debt vs. Competition

OncoSec Medical is regarded third in total debt category among its peers. Total debt of Health Care industry is now estimated at about 43.86 Million. OncoSec Medical retains roughly 6.17 Million in total debt claiming about 14% of equities under Health Care industry.
Total debt  Revenue  Workforce  Capitalization  Valuation

OncoSec Cash Per Share vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

OncoSec Medical

Total Debt

 = 

Bonds

+

Notes

 = 
6.17 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

OncoSec Medical

Cash Per Share

 = 

Total Cash

Average Shares

 = 
0.50 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.

OncoSec Cash Per Share Comparison

OncoSec Medical is currently under evaluation in cash per share category among its peers.

OncoSec Medical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in OncoSec Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, OncoSec Medical will eventually generate negative long term returns. The profitability progress is the general direction of OncoSec Medical's change in net profit over the period of time. It can combine multiple indicators of OncoSec Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company was incorporated in 2008 and is headquartered in Pennington, New Jersey. Oncosec Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 54 people.

OncoSec Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on OncoSec Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of OncoSec Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the OncoSec Medical's important profitability drivers and their relationship over time.

Use OncoSec Medical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OncoSec Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoSec Medical will appreciate offsetting losses from the drop in the long position's value.

OncoSec Medical Pair Trading

OncoSec Medical Pair Trading Analysis

The ability to find closely correlated positions to OncoSec Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OncoSec Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OncoSec Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OncoSec Medical to buy it.
The correlation of OncoSec Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OncoSec Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OncoSec Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OncoSec Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your OncoSec Medical position

In addition to having OncoSec Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Insurance Thematic Idea Now

Insurance
Insurance Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Insurance theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in OncoSec Stock

If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data